Provider

GE Research has received a grant from the NIH to develop sensors that can be embedded into mobile devices to detect COVID-19 particles on their surfaces.   

The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.   

Also, startup creates wearable tech to tackle head injuries in sport.

Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be used to measure blood pressure.   

The study found that patients using AliveCor Kardia Mobile required fewer follow-up EGCs and cardiac monitoring than their peers in the control group.

Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution. 

European digital health coaching company, Liva Healthcare and global biotechnology organisation, Amgen, have announced a partnership to make cardiac rehabilitation accessible to patients following a heart attack.

The manufacturer of the electronic artificial urinary sphincter aims to develop its device for treating urinary incontinence.

The integration is aimed at boosting data collection. 

The new research collaboration will zero in on athletes across Pac-12 universities.